EMCC European Monitoring Centre on Change



Geographic Location

Country: Germany
Region: Berlin
Location of affected unit(s): Berlin


Sector: Professional services
Scientific research and development
72.11 - Research and experimental development on biotechnology
Number Employed: 5000
Group: Bayer AG

Employment Effects

Announcement Date: 11-02-2020
Planned Job Reductions min: 400
Planned Job Reductions max: 400
Type of Restructuring: Outsourcing
Employment Effect Start: 11-02-2020
Foreseen End Date: 01-07-2020
Other Job Reduction Measures: 400

Additional Information

In February 2020, the German pharmaceutical company Bayer announced that it will outsource one part of its research to Nuvisan, which will affect 400 employees from Bayer's unit in Berlin. The outsourced research department focuses on small molecular agents. Details on the deal, which is expected to be finalised in mid-2020, have not been published. Nuvisan plans to take on all 400 employees from Bayer's unit. 

Currently, Nuvisan has around 400 employees in Germany.